Tedisamil is a blocker of K+ currents in cardiac tissues, exerts bradycardic effects and has shown clinical efficacy in angina pectoris. It is an antiarrhythmic drug with predominantly class III activity. References: Démolis JL, Martel C, Funck-Brentano C, Sachse A, Weimann HJ, Jaillon P. Effects of tedisamil, atenolol and their combination on heart and rate-dependent QT interval in healthy volunteers. Br J Clin Pharmacol. 1997 Oct;44(4):403-9. PubMed PMID: 9354317; PubMed Central PMCID: PMC2042860.

纯度：≥98%

CAS：90961-53-8